![0.2ml Esketamine Spravato Nasal Spray, Treatment: Depression, Non prescription, Treatment: Antidepresstion, Rs 600/box | ID: 24217482833 0.2ml Esketamine Spravato Nasal Spray, Treatment: Depression, Non prescription, Treatment: Antidepresstion, Rs 600/box | ID: 24217482833](https://5.imimg.com/data5/SELLER/Default/2021/11/FE/SK/SE/139453706/ss6hswnpt0x71-500x500.jpg)
0.2ml Esketamine Spravato Nasal Spray, Treatment: Depression, Non prescription, Treatment: Antidepresstion, Rs 600/box | ID: 24217482833
![These highlights do not include all the information needed to use SPRAVATO® safely and effectively. See full prescribing information for SPRAVATO®. SPRAVATO® (esketamine) nasal spray, CIII Initial U.S. Approval: 1970 (ketamine) These highlights do not include all the information needed to use SPRAVATO® safely and effectively. See full prescribing information for SPRAVATO®. SPRAVATO® (esketamine) nasal spray, CIII Initial U.S. Approval: 1970 (ketamine)](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=spravato-01.jpg&id=498018)
These highlights do not include all the information needed to use SPRAVATO® safely and effectively. See full prescribing information for SPRAVATO®. SPRAVATO® (esketamine) nasal spray, CIII Initial U.S. Approval: 1970 (ketamine)
![FDA approves Spravato, a fast-acting, Ketamine-like nasal spray to treat people with severe depression | South China Morning Post FDA approves Spravato, a fast-acting, Ketamine-like nasal spray to treat people with severe depression | South China Morning Post](https://cdn1.i-scmp.com/sites/default/files/styles/og_image_scmp_generic/public/images/methode/2019/03/06/34c19f44-3fba-11e9-b20a-0cdc8de4a6f4_image_hires_111332.jpg?itok=c4Tzb-Wk&v=1551842015)
FDA approves Spravato, a fast-acting, Ketamine-like nasal spray to treat people with severe depression | South China Morning Post
![New Spravato FDA Approval Opens The Door to New Patients, Says Sandhya Prashad, M.D. - Sandhya Prashad, MD New Spravato FDA Approval Opens The Door to New Patients, Says Sandhya Prashad, M.D. - Sandhya Prashad, MD](https://sprashadmd.com/wp-content/uploads/2020/08/Spravato-_-Sandhya-Prashad-MD-social-post.png)
New Spravato FDA Approval Opens The Door to New Patients, Says Sandhya Prashad, M.D. - Sandhya Prashad, MD
![J&J depression spray Spravato, carrying big expectations and restrictions, scores FDA nod | Fierce Pharma J&J depression spray Spravato, carrying big expectations and restrictions, scores FDA nod | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1551886134/spravato.jpg?VersionId=1w_nLNSPD91igaX5OW4fYvbUVZY3kvgn)